| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Revenue | $925.6M | +17.8% |
| Cost of Revenue | $246.4M | -3.9% |
| Gross Profit | $679.2M | +28.3% |
| R&D Expense | $275.3M | +29.9% |
| SG&A Expense | $189.1M | +24.5% |
| Operating Income | -$185.2M | +18.9% |
| Interest Expense | $4.9M | +0.4% |
| Pre-tax Income | -$175.9M | +24.1% |
| Income Tax | $2.9M | +796.6% |
| Net Income | -$180.2M | +28.0% |
| EPS (Basic) | -$2.67 | +31.2% |
| EPS (Diluted) | -$2.67 | +31.2% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $625.7M | +132.9% |
| Short-term Investments | $254.1M | -54.6% |
| Accounts Receivable | $234.3M | +3.6% |
| Current Assets | $1.15B | +3.5% |
| Total Assets | $1.42B | -0.6% |
| Current Liabilities | $988.4M | +91.7% |
| Total Liabilities | $1.06B | -2.6% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $53.8M | +1383.7% |
| Capital Expenditures | $3.1M | -46.1% |
| Investing Cash Flow | $279.9M | +1516.6% |
| Financing Cash Flow | $23.4M | -47.0% |
| Free Cash Flow | $50.7M | +2451.7% |
| Stockholders' Equity |
| $340.4M |
| +5.5% |